Navigation Links
Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool
Date:11/16/2009

DETROIT, Nov. 16 /PRNewswire-USNewswire/ -- After more than 10 years of research and development, the Barbara Ann Karmanos Cancer Institute announced its launch of a new company to build and market a breast cancer screening device invented at Karmanos. The innovative technology developed as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as SoftVue, will be marketed under the new spin-off company called Delphinus Medical Technologies, LLC. The company has already secured sale commitments for the SoftVue system from several health institutions nationally and internationally.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO)

More than 300 women were involved in the initial clinical studies, which confirmed that SoftVue accurately and safely identifies breast cancer. SoftVue uses multi-parametric ultrasound and sophisticated computer algorithms rather than X-rays. The SoftVue exam takes about one minute, does not involve radiation or compression as the current mammography, and is a fraction of the cost of MRI (magnetic resonance imaging). It's believed that it will help reduce the number of false positives that can occur with mammography and thereby reduce unnecessary biopsies.

"I'm proud to work with a dedicated team of physicians, scientific researchers and other medical experts who are committed to having a world free of cancer," said Ann G. Schwartz, Ph.D., MPH, interim president and chief executive officer, Karmanos Cancer Institute. "Neb Duric, Ph.D., and Peter J. Littrup, M.D., as well as their entire research team, never lost sight of the significance of achieving their goal. They continue to work tirelessly so this incredible imaging technology can go beyond the trial stage to benefit more people and help save lives."

Delphinus, which is Latin for dolphin, symboliz
'/>"/>

SOURCE Karmanos Cancer Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
2. Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative
3. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
4. Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
5. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
6. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
7. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
8. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
9. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
10. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women
11. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- Just days before the government of Sierra ... spread of Ebola, World Vision will begin a massive delivery ... private donations. McKesson, the largest healthcare services company ... affiliate McKesson Medical-Surgical donated four million pairs of latex gloves ... Sierra Leone,s needs for the next five months* ...
(Date:9/18/2014)... VIEW, Calif. and CHESTERBROOK, Pa. ... (Nasdaq: VVUS ) and Auxilium Pharmaceuticals, Inc. ... U.S. Food and Drug Administration (FDA) has approved a supplemental ... is now the only FDA-approved erectile dysfunction (ED) medication indicated ... sexual activity. STENDRA is a prescription medication in ...
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 ... Industry" and "2014 Market Research Report on Global ... its store. Photo - http://photos.prnewswire.com/prnh/20140917/146748 ... on Global Methyl Methacrylate (MMA) Industry" is a ... China and Global Methyl Methacrylate (MMA) ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
(Date:9/18/2014)... September 18, 2014 Relias Learning, the leader ... human services markets, today announced it has been named to ... private companies in America. , In the three-year period from ... up almost 2,000 spots on the Inc. 5000 list to ... , “The industries we serve continue to grow, and ...
(Date:9/18/2014)... PlatinumCode, a leading manufacturer and supplier ... the healthcare industry, announced earlier this month that ... their profits of the sale of eligible pink ... announcement, PlatinumCode has launched various marketing efforts to ... hospital labs with their popular “Pink Packs” of ...
(Date:9/18/2014)... “Awesome” is the way Emily W. describes her ... Internship Program at ARDX ( http://www.ardx.net ). Her ... as “Inspirational” and “Life-changing,” respectively. None of these ... be doing during their summer internship. Stacie was ... mindless tasks,” but, instead she was doing real, meaningful ...
(Date:9/18/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, 2014 (HealthDay ... stress disorder symptoms are almost three times more likely to ... The findings don,t prove a direct link between PTSD ... also possible that certain women are prone to food addiction ... research seems to add to existing evidence connecting PTSD to ...
(Date:9/18/2014)... 18, 2014 Fit Body Boot Camp ... fitness business in the country and its popularity, as both ... to grow enormously in 2014. , The company’s annual ... taking place in Costa Mesa, CA on September 26 and ... conferences yet. Founder Bedros Keuilian, who is also considered the ...
Breaking Medicine News(10 mins):Health News:Relias Learning Named to Inc. 5000 List for Second Consecutive Year 2Health News:PlatinumCode Commits to Donating Five Percent of Profits from the sale of Pink Products to Support Breast Cancer Awareness 2Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3
... Sales increase 73% over Third Quarter 2007, EMERYVILLE, ... ) today reported its financial results,for the three and ... of $12.2 million, or $0.21 per diluted share, for ... $0.6 million, or $0.01 per diluted share,in the same ...
... 6 Pharmos Corporation,(Nasdaq: PARS ) today reported results ... a net loss of $2.8 million, or $0.11 per,share, for ... $3.5 million,or $0.14 per share, in the third quarter 2007. ... The decrease in net loss for the third quarter ...
... and service levels were key reasons, says union,president, ... Paul N. Urick, R.Ph., announced today that the ... its Participating Employers Health,and Welfare Fund have agreed ... members pharmacy coverage through FutureScripts. UFCW Local,1776,s new ...
... room doctors, study says , , THURSDAY, Nov. 6 (HealthDay ... at the hands of peers, immediate one-on-one mentoring on ... their risk of becoming victims again, a new study ... for assault injuries -- including gunshot, knife and fist-fight ...
... mostly young children -- infected, bringing total to 79, CDC ... cases of people becoming infected with salmonella traced to dry ... , The outbreak, which started in 2006, marks the first ... source of the bacterial infection in people. , As of ...
... Company Reports Seventeenth Consecutive Quarter Of Growth In ... Inc.,(Nasdaq: GXDX ), a specialized laboratory services ... third quarter of 2008, which includes a,$2.5 million ... prior,periods. This compares to revenues of $16.2 million ...
Cached Medicine News:Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 3Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 4Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 5Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 6Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 7Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 8Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 9Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 10Health News:Pharmos Corporation Reports 2008 Third Quarter Results 2Health News:Pharmos Corporation Reports 2008 Third Quarter Results 3Health News:Pharmos Corporation Reports 2008 Third Quarter Results 4Health News:Pharmos Corporation Reports 2008 Third Quarter Results 5Health News:FutureScripts(R) Wins Business of UFCW Local 1776 for Pharmacy Benefits 2Health News:FutureScripts(R) Wins Business of UFCW Local 1776 for Pharmacy Benefits 3Health News:FutureScripts(R) Wins Business of UFCW Local 1776 for Pharmacy Benefits 4Health News:Counseling Can Combat Youth Violence 2Health News:Salmonella Outbreak Tied to Dry Dog Food Continues 2Health News:Salmonella Outbreak Tied to Dry Dog Food Continues 3Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 2Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 3Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 4Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 5Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 6Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 7Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 8Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 9Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 10
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
Medicine Products: